Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis
Primary Purpose
Carcinoma, Non Small Cell Lung
Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
CT-scan, PET-scan
Sponsored by
About this trial
This is an interventional diagnostic trial for Carcinoma, Non Small Cell Lung
Eligibility Criteria
Inclusion Criteria: -Patients with non small cell lung cancer and atelectasis, who are eligible for surgery. Exclusion Criteria: age < 18 years pregnancy
Sites / Locations
- Radboud University Nijmegen Medical CentreRecruiting
Outcomes
Primary Outcome Measures
Histological validation of CT-PET image fusion.
Secondary Outcome Measures
Full Information
NCT ID
NCT00184964
First Posted
September 12, 2005
Last Updated
June 3, 2008
Sponsor
Radboud University Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00184964
Brief Title
Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis
Official Title
The Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis With Histological Examination of the Resected Specimen
Study Type
Interventional
2. Study Status
Record Verification Date
June 2008
Overall Recruitment Status
Unknown status
Study Start Date
June 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Radboud University Medical Center
4. Oversight
5. Study Description
Brief Summary
CT-PET image fusion has the potential to differentiate 'tumor' from 'atelectasis' much better than the CT-scan in patients with non-small cell lung cancer who also have atelectasis.
This however has never been validated on a histological level. In this study patients with non small cell lung cancer and atelectasis who are eligible for surgery undergo a CT-scan and a PET-scan prior to surgery.
The resection specimen will be compared to the preoperative imaging.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carcinoma, Non Small Cell Lung
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
15 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
CT-scan, PET-scan
Primary Outcome Measure Information:
Title
Histological validation of CT-PET image fusion.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
-Patients with non small cell lung cancer and atelectasis, who are eligible for surgery.
Exclusion Criteria:
age < 18 years
pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dominic A Schinagl, MD
Phone
+31243614515
Email
d.schinagl@rther.umcn.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan Bussink, MD, PhD
Organizational Affiliation
Radiation oncologist, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Official's Role
Study Director
Facility Information:
Facility Name
Radboud University Nijmegen Medical Centre
City
Nijmegen
State/Province
Gelderland
ZIP/Postal Code
6500HB
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dominic A Schinagl, MD
Phone
+31243614515
Email
d.schinagl@rther.umcn.nl
First Name & Middle Initial & Last Name & Degree
Dominic A Schinagl, MD
12. IPD Sharing Statement
Learn more about this trial
Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis
We'll reach out to this number within 24 hrs